These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33816266)

  • 1. Molecular Characteristics, Prognostic Value, and Immune Characteristics of m
    Geng X; Zhang Y; Zeng Z; Zhu Z; Wang H; Yu W; Li Q
    Front Oncol; 2021; 11():629718. PubMed ID: 33816266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Significance of an m6A Reader Gene,
    Deng X; Jiang Q; Liu Z; Chen W
    Front Mol Biosci; 2020; 7():68. PubMed ID: 32391379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and clinical evaluation of N6-methyladenosine risk signature of YTHDC2, IGF2BP2, and HNRNPC in head and neck squamous cell carcinoma.
    Yue Q; Xu L; Zhang D
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2022 Dec; 40(6):704-709. PubMed ID: 36416324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma.
    Paramasivam A; George R; Priyadharsini JV
    Am J Cancer Res; 2021; 11(7):3688-3697. PubMed ID: 34354868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Two m6A Readers
    Li S; Wu Q; Liu J; Zhong Y
    Front Genet; 2022; 13():903634. PubMed ID: 35646049
    [No Abstract]   [Full Text] [Related]  

  • 7. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
    Hu Y; Chen J; Liu M; Feng Q; Peng H
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma.
    Zhou X; Han J; Zhen X; Liu Y; Cui Z; Yue Z; Ding L; Xu S
    Front Oncol; 2020; 10():718. PubMed ID: 32547941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF2BP2 promotes head and neck squamous carcinoma cell proliferation and growth via the miR-98-5p/PI3K/Akt signaling pathway.
    Yu D; Xiao Z; Zou Z; Lin L; Li J; Tan J; Chen W
    Front Oncol; 2023; 13():1252999. PubMed ID: 37936610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis of N6-Methyladenosine-Related Enhancer RNAs Identifies Distinct Prognosis and Tumor Immune Micro-Environment Patterns in Head and Neck Squamous Cell Carcinoma.
    Cai H; Liang J; Jiang Y; Tan R; Hou C; Hou J
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatical identification of key genes regulated by IGF2BP2-mediated RNA N6-methyladenosine and prediction of prognosis in hepatocellular carcinoma.
    Wei Q
    J Gastrointest Oncol; 2021 Aug; 12(4):1773-1785. PubMed ID: 34532127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
    Arumugam P; George R; Jayaseelan VP
    Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of m
    Yang Z; Ming X; Huang S; Yang M; Zhou X; Fang J
    Front Oncol; 2021; 11():764798. PubMed ID: 34917507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma.
    Tan L; Qin Y; Xie R; Xia T; Duan X; Peng L; You R; Liu Y; Zou X; Zhang M; Lin M; Chen M
    Theranostics; 2022; 12(17):7267-7288. PubMed ID: 36438489
    [No Abstract]   [Full Text] [Related]  

  • 17. The m6A reader protein YTHDC2 is a potential biomarker and associated with immune infiltration in head and neck squamous cell carcinoma.
    Li Y; Zheng JN; Wang EH; Gong CJ; Lan KF; Ding X
    PeerJ; 2020; 8():e10385. PubMed ID: 33304653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
    Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
    Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m
    Yi L; Wu G; Guo L; Zou X; Huang P
    Mol Ther Nucleic Acids; 2020 Sep; 21():299-314. PubMed ID: 32622331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.